References
- Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: Role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. J Contr Rel 2002; 79: 29–40
- Arshady R. Albumin microspheres and microcapsules: Methodology of manufacturing techniques. J Contr Re 1990; 14: 111–131
- Beaman JM, Akhtar N, Goldie DJ. Down's syndrome screening using free beta hCG: Instability can significantly increase the Down's risk estimate. Ann Clin Biochem 1996; 33: 525–529
- Brandao J, Mogo C, Silva BC. Potential energy surface for H2O((3)A(")) from accurate ab initio data with inclusion of long-range interactions. J Chem Phys 2004; 121: 8861–8868
- Burger JJ, Tomlinson E, de Roo JE, Palmer J. Technetium-99m labeling of albumin microspheres intended for drug targeting. Methods Enzymol 1985; 112: 43–56
- Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol 1996; 48: 1147–1152
- de Campos AM, Diebold Y, Carvalho EL, Sanchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity. Pharm Res 2004; 21: 803–810
- de Silva LP, Ciocca Mde L, Furlong EB. Evaluation of the AOAC 985.29 enzimic gravimetric method for determination of dietary fiber in oat and corn grains. Arch Latinoam Nutr 2003; 53: 393–399
- Enriquez de Salamanca A, Diebold Y, Calonge M, Garcia-Vazquez C, Callejo S, Uila A, et al. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci 2006; 47: 1416–1425
- Gupta PK, Hung CT. Albumin microspheres. II: Applications in drug delivery. J Microencapsulation 1989; 6: 463–472
- Harmia T, Speiser P, Kreuter J. A solid colloidal drug delivery system for the eye: Encapsulation of pilocarpin in nanoparticles. J Microencapsulation 1986; 3: 3–12
- Jha SK, D'Souza SF. Preparation of polyvinyl alcohol-polyacrylamide composite polymer membrane by gamma-irradiation for entrapment of urease. J Biochem Biophys Methods 2005; 62: 215–218
- Kramer PA. Letter: Albumin microspheres as vehicles for achieving specificity in drug delivery. J Pharm Sci 1974; 63: 1646–1647
- Lim ST, Martin GP, Berry DJ, Brown MB. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Contr Rel 2000; 66: 281–292
- Losa C, Calvo P, Castro E, Vila-Jato JL, Alonso MJ. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol 1991; 43: 548–552
- Losa C, Marchal-Heussler L, Orallo F, Vila Jato JL, Alonso MJ. Design of new formulations for topical ocular administration: Polymeric nanocapsules containing metipranolol. Pharm Res 1993; 10: 80–87
- Maury M, Murphy K, Kumar S, Shi L, Lee G. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer. Eur J Pharm Biopharm 2005; 59: 565–573
- Natsume H, Sugibayashi K, Morimoto Y. Preparation and evaluation of biodegradable albumin microspheres containing mitomycin C. Int J Pharm 1990; 58: 79–87
- Sanchez A, Tobio M, Gonzalez L, Fabra A, Alonso MJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 2003; 18: 221–229
- Verma S, Corbett MC, Marshall J. A prospective, randomized, double-masked trial to evaluate the role of topical anesthetics in controlling pain after photorefractive keratectomy. Ophthalmology 1995; 102: 1918–1924
- Zimmer A, Mutschler E, Lambrecht G, Mayer D, Kreuter J. Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system. Pharm Res 1994; 11: 1435–1442
- Zolle I, Rhodes BA, Wagner HN, Jr. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. Int J Appl Radiat Isot 1970; 21: 155–167